STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #200 by analyst upside · 2026-06-27
TNYA
Tenaya Therapeutics, Inc.
Healthcare · Market Cap $156M · P/E 0x
ANALYST PRICE TARGET
+457.5%
implied upside to consensus target
Current Price $0.72
Consensus Target $4.0
Bull Target $8.0
Bear Target $2.0
Analysts Covering 6
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
4
Hold
0
Sell
0
52-Week Low $0.53
52-Week High $2.35
YTD Return -2.4%
FUNDAMENTALS
Market Cap $156M
P/E Ratio (TTM) N/A
Forward P/E -1.7x
EPS (TTM) $-0.44
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $0M
Profit Margin N/A
52-WEEK RANGE
52-Week Low $0.53
52-Week High $2.35
Current Price $0.72
Bear Target $2.0
Bull Target $8.0
● Now $0.72 ● Target $4.0
TRADING DATA
Avg Volume 3.7M
YTD Return -2.4%
Analyst Count 6
Consensus Buy
Upside to Target +457.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Tenaya Therapeutics, Inc. (TNYA) is currently trading at $0.72 with a Wall Street consensus price target of $4.0, implying potential upside of 457.5% over the next 12 months. 6 analysts currently cover TNYA, with a consensus rating of Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $8.0, while the most cautious has a target of $2.0.

TNYA operates in the Healthcare sector with a market capitalisation of $156M. The stock is down 2.4% year-to-date and is currently trading near the lower end of its 52-week range of $0.53 – $2.35.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for TNYA, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital — Reiterated
Buy → Buy 2026-03-12 33% win rate (6 calls)
Canaccord Genuity — Reiterated
Buy → Buy 2025-12-18 Building track record
HC Wainwright & Co. — Reiterated
Buy → Buy 2025-12-12 31% win rate (48 calls)
Chardan Capital — Reiterated
Buy → Buy 2025-12-12 33% win rate (6 calls)
Chardan Capital — Reiterated
Buy → Buy 2025-11-10 33% win rate (6 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-09-02 31% win rate (48 calls)
HC Wainwright & Co. reit
Buy → Buy 2025-08-27 31% win rate (48 calls)
Chardan Capital — Reiterated
Buy → Buy 2025-08-07 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →